Printed from acutecaretesting.org
Articles by James O Westgard
Showing articles by "James O Westgard"
Article
October 2010
Significant figures
The appropriate number of significant figures is important in order to have a meaningful level of resolving power when reporting analytical concentrations. Various methods or criteria can be used when estimating how many significant figures are needed. In most cases three significant figures (two true plus one...
Information management
D-dimer
Troponins
Article
July 2010
The significance of base excess (BEB) and base excess in the extra cellular fluid compartment (BEEcf)
BACKGROUND: Besides actual pH, base excess (ctH+B (mmol/L)) is of major importance since it is meant to reflect lactate acidosis due to fetal hypoxia; in vivo BEB is not independent from pCO2.
Independence is achieved by using the extended extracellular fluid (Ecf) for dilution of hemoglobin (cHbB), reducing cHbB to ...
Blood gases/acid-base
Neonatology
Point-of-care testing
Lactate
Hemoglobins
Article
July 2010
Cardiac biomarkers for acute coronary syndrome and ongoing myocardial damage in heart failure
The growing role of cardiac markers has
been elucidated in patients with acute coronary syndrome, heart
failure and other cardiovascular diseases.
The markers can be cytosolic like
heart-type fatty-acid-binding protein (H-FABP) and creatine kinase
MB (CKMB), myofibrillary like troponin T (TnT) and cardio-endocrine...
Cardiac markers
Troponins
Natriuretic peptide
Article
July 2010
FAQ concerning the acid-base status of the blood
Some of the frequently asked questions are: Should we use BE (base excess) or SID (strong ion difference) as a measure of a metabolic acid-base disturbance? Is there any difference between BB (buffer base) and SID? Should we use SBE (standard base excess), i.e. BE referring to the expanded extracellular fluid or...
Blood gases/acid-base
Point-of-care testing
Glucose
Lactate
Creatinine/urea
Hemoglobins
Article
July 2010
Diagnosis of DVT with D-dimer testing and the Wells score
The following is a copy of an article from Evidence-Based Practice, 2007; 10(12):1-2.
Venous thromboembolism refers to a spectrum of disease that includes both pulmonary embolus and deep-venous thrombosis (DVT).
More than 250,000 people in the United States are diagnosed annually with venous thromboembolic disease;...
Coagulation/fibrinolysis
D-dimer
Article
April 2010
Benefit of using a D-dimer assay with a high clinical specificity
CONTEXT: Sensitive D-dimer assays have been developed to exclude the diagnosis of deep vein thrombosis (DVT) and have exhibited great success when used in conjunction with a diagnostic algorithm, including pretest probability scoring and a compression ultrasound (CUS).
Improving specificity of D-dimer assays would...
Coagulation/fibrinolysis
D-dimer
Article
April 2010
NT-proBNP as a biomarker of cardioembolic stroke
In about 30-40 % of ischemic strokes, even after an extensive clinical investigation, it is not possible to determine any one etiology. It is possible that a fraction of these strokes, named cryptogenic, happen after an episode of paroxystic atrial fibrillation (AF) that was not registered. Strokes due to atrial...
Cardiac markers
Natriuretic peptide
Article
June 2009
Acute care testing at the point-of-care: now and in the future
The field of point-of-care testing (POCT) is entering a period of rapid expansion. This expansion is being driven by new evidence for clinical effectiveness of POCT, and new technologies that allow consolidation of testing onto smaller platforms.
Technological improvements will also lead to increased accuracy for...
Glucose
Blood gases/acid-base
Point-of-care testing
Quality assurance
Lactate
Creatinine/urea
Hemoglobins
Kidneys/fluids
Article
June 2009
The utility of natriuretic peptide in the management of patients with acute and chronic heart failure: Insights from randomized controlled trials
Patients with heart failure (HF) experience significant morbidity and mortality and those admitted for acute decompensated HF are at particularly high risk for adverse events.
Hospitalization represents the major component of the high cost associated with the management of patients with HF. Accordingly, early and...
Cardiac markers
Article
June 2009
D-dimer as a rule-out test for deep venous thrombosis: Gold standards and bias in negative predictive value
Recent studies of D-dimer as a “rule-out” test for deep venous thrombosis (DVT) frequently have used duplex ultrasound rather than venography as the gold standard.
Because duplex ultrasound has limited ability to image the calf veins, there is potential for ultrasound studies to classify patients with calf DVT as...
Coagulation/fibrinolysis
Hemoglobins
D-dimer
